QuidelOrtho Appoints Erich Wolff as Executive Vice President, Strategy & Corporate Development.

QuidelOrtho welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development. Wolff brings over two decades of leadership experience in strategy, M&A, and business development across healthcare, diagnostics, and MedTech sectors. He will lead QuidelOrtho's enterprise strategy, business development, government affairs, and portfolio management functions. Wolff's experience in revitalizing companies and executing high-impact growth strategies will be valuable as QuidelOrtho continues to advance diagnostics for a healthier future.

QuidelOrtho (NASDAQ: QDEL), a global leader in diagnostic healthcare solutions, has appointed Erich Wolff as Executive Vice President of Strategy & Corporate Development, reporting to CEO Brian Blaser. Wolff brings over 20 years of leadership experience in healthcare, diagnostics, and MedTech sectors [1].

Previously serving as Buyouts Lead at Partners Group ($174B AUM), Wolff held senior roles at BD and Medtronic. At Medtronic, he revitalized the global diabetes business and managed corporate development for $11.5B neurosciences and diabetes units. At BD, he led key transactions including the embecta spinoff and $1.5B Parata Systems acquisition [1].

Wolff's appointment follows a series of strategic leadership changes at QuidelOrtho. The company has recently announced the appointment of Devon Burek as Senior Vice President of Global Quality and Sergio Gadaleta as Senior Vice President of Clinical and Regulatory Affairs [2]. These appointments reflect QuidelOrtho's commitment to strengthening its leadership team and driving growth in its molecular diagnostics business.

QuidelOrtho's strategic shift in molecular diagnostics includes the planned acquisition of LEX Diagnostics for approximately $100 million upon FDA clearance, while discontinuing its Savanna platform development [2]. This strategic decision aligns with the company's comprehensive review under CEO Brian J. Blaser to drive shareholder value.

The appointment of Erich Wolff underscores QuidelOrtho's commitment to strategic growth and innovation in the diagnostics sector. With his extensive experience in revitalizing companies and executing high-impact growth strategies, Wolff is well-positioned to lead QuidelOrtho's enterprise strategy, business development, government affairs, and portfolio management functions.

References:
[1] https://www.stocktitan.net/news/QDEL/quidel-ortho-welcomes-erich-wolff-as-executive-vice-president-btenfilxcvjp.html
[2] https://www.stocktitan.net/news/QDEL/